Semler Scientific, Strive, Kindlymbd, and Empery Digital have a strange problem in common. All of them trade below the value of their cryptocurrency holdings. In market terms, their market net asset value (MNAV) sits below 1. That means the stock price is lower than the per-share value of their BTC or other crypto assets. This may sound like a buying opportunity, but it comes with a catch.

When MNAV falls below 1, these companies cannot issue new shares to buy more Bitcoin without hurting existing shareholders. Issuing stock at a discount effectively dilutes value and erodes the capital structure. This blocks the core “treasury playbook” many crypto-heavy firms use, where they raise equity to acquire more digital assets and ride the upside.

The situation leaves these stocks stuck in a kind of financial limbo. They hold valuable crypto assets, but the market refuses to price the stock at or above that value. This often happens when investor sentiment cools or when macro conditions push traders toward cash rather than speculative assets. The result is “dead money” that just sits there until Bitcoin rallies hard enough to push the MNAV back above parity.

The irony is that if BTC has a sharp upward move, these same stocks could rocket as the embedded value gap closes. Investors who accumulate during the discount phase could benefit, but until Bitcoin delivers a major breakout, these companies are practically handcuffed in their growth strategies. It is a high-stakes waiting game, one that could pay off spectacularly when the crypto tide inevitably turns.